Los Angeles, CA -- (SBWire) -- 02/15/2019 --QY Research has come up with a newly published report on global Radiopharmaceutical market in its database that provides an in-depth analysis of the key market insights, its future trends, and developments, profiles of leading players, key restraints and drivers, segmentation and forecasting. The report highlights the Radiopharmaceutical market size and CAGR of the important segments, thus providing quick relevant information about the global Radiopharmaceutical market.

The global Radiopharmaceutical market is valued at 4940 million US$ in 2018 is expected to reach 9520 million US$ by the end of 2025, growing at a CAGR of 8.6% during 2019-2025.

Get PDF template of this report: https://www.qyresearch.com/sample-form/form/964756/global-radiopharmaceutical-trends-and-forecast

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

In the next few years, Radiopharmaceuticals industry will maintain increasing at a relatively high growth rate. Investors are still optimistic about this area; the future will still have more new investment enter the field.

The classification of Radiopharmaceuticals includes Diagnostic Radioisotopes, Therapeutic Radioisotopes. The revenue proportion of Diagnostic Radioisotopes in 2016 is about 77%, and the proportion is in decreasing trend from 2012 to 2017. The Therapeutic Radioisotopes is enjoying more and more market share.

Radiopharmaceuticals are widely used in Oncology, Cardiology and Other disease diagnosis and treatment. The most of radiopharmaceuticals is used in Oncology, and the sales proportion in 2016 is about 60%.

This report focuses on Radiopharmaceutical volume and value at global level, regional level and company level. From a global perspective, this report represents overall Radiopharmaceutical market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

Major Key Manufacturers of Radiopharmaceutical Market are:

Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea

Radiopharmaceutical market includes market size, segmentation data and geographical analysis of market growth trends, leading companies, and microeconomic information.

Major Classification as follows:

Actinium-225
Lutetium-177
Radium-223
Holmium-166
Other

Major Application as follows:

Oncology
Cardiology
Other

Get Complete Report in your Inbox within 24 hours: https://www.qyresearch.com/settlement/pre/0905fc478f5e0c01d0cebd98e917bdd0,0,1,Global%20Radiopharmaceutical%20Trends%20and%20Forecast%202019

Reasons to buy this report:

The Radiopharmaceutical report is designed in a method that assists clients to acquire a complete knowledge of the overall market scenario and the important sectors.

This report consists of a detailed overview of Radiopharmaceutical market dynamics and comprehensive research.

Explore further Radiopharmaceutical market opportunities and identify high potential categories based on detailed volume and value analysis.

Detail information on competitive landscape, Radiopharmaceutical recent market trends and changing technologies that can be useful for the companies which are competing in the Radiopharmaceutical industry.

Gaining knowledge about Radiopharmaceutical market competitive landscape based on detailed brand share analysis to plan an effective market positioning.

About QYResearch
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become a brand of quality assurance in the consulting industry.